20931330|t|Do CYP3A and ABCB1 genotypes influence the plasma concentration and clinical outcome of donepezil treatment?
20931330|a|PURPOSE: The aim of our study was to evaluate the impact of CYP3A4, CYP3A5, and ABCB1 polymorphisms on donepezil disposition and clinical outcome. METHODS: Fifty-four Italian patients diagnosed with probable mild to moderate Alzheimer's disease, treated with donepezil (37 patients 5 mg/day, 17 patients 10 mg/day) were genotyped for CYP3A4 (*1B, *3, and *4), CYP3A5 (*2, *3, and *6) and ABCB1 (3435C>T, 2677G>T/A, and 1236C>T) polymorphisms. All patients were evaluated for the degree of cognitive impairment with Mini Mental State Examination (MMSE) screening test at baseline (before treatment) and after at least 3 months of donepezil treatment at stable dose, when the drug plasma levels were measured. RESULTS: Three patients carried one detrimental CYP3A4 allelic variant, and 12 carried one functional CYP3A5*1 allele. No statistically significant association was found between CYP3A4 or CYP3A5 genotypes and plasma donepezil concentrations, or between genotypes and clinical response (as measured by change in MMSE score). Nine ABCB1 haplotypes were observed, the most common being 1236C/2677G/3435C (46%) and 1236T/2677T/3435T (41%). Patients homozygous for the T/T/T haplotype had slightly though not significantly lower plasma donepezil concentration-to-dose ratios than those carrying other genotypes [median (95% CI) 0.18 (0.13-0.45) vs. 0.31 (0.30-0.44) mg/l/mg/kg, respectively]. These patients also showed a slightly better clinical response (as measured by change in MMSE score) than the other genotype groups [median (95% CI) 0 (-1.3 to 3.3) vs. -1.0 (-2.1 to 0.0), respectively]. CONCLUSIONS: Our data suggest that the CYP3A4 and CYP3A5 polymorphisms are unlikely to influence donepezil metabolism and/or clinical outcome. On the other hand, the ABCB1 polymorphisms may play a role in donepezil disposition and clinical outcome.
20931330	3	8	CYP3A	Gene	1576
20931330	13	18	ABCB1	Gene	5243
20931330	88	97	donepezil	Chemical	MESH:D000077265
20931330	169	175	CYP3A4	Gene	1576
20931330	177	183	CYP3A5	Gene	1577
20931330	189	194	ABCB1	Gene	5243
20931330	212	221	donepezil	Chemical	MESH:D000077265
20931330	284	292	patients	Species	9606
20931330	334	353	Alzheimer's disease	Disease	MESH:D000544
20931330	368	377	donepezil	Chemical	MESH:D000077265
20931330	382	390	patients	Species	9606
20931330	404	412	patients	Species	9606
20931330	443	449	CYP3A4	Gene	1576
20931330	469	475	CYP3A5	Gene	1577
20931330	497	502	ABCB1	Gene	5243
20931330	504	511	3435C>T	DNAMutation	tmVar:c|SUB|C|3435|T;HGVS:c.3435C>T;VariantGroup:0;CorrespondingGene:5243;RS#:1045642;CorrespondingSpecies:9606;CA#:4327768
20931330	513	522	2677G>T/A	DNAMutation	tmVar:|SUB|G|2677|T,A;HGVS:c.2677G>T,A;VariantGroup:1;CorrespondingGene:5243;CorrespondingSpecies:9606
20931330	528	535	1236C>T	DNAMutation	tmVar:c|SUB|C|1236|T;HGVS:c.1236C>T;VariantGroup:2;CorrespondingGene:5243;RS#:1128503;CorrespondingSpecies:9606;CA#:201020
20931330	556	564	patients	Species	9606
20931330	598	618	cognitive impairment	Disease	MESH:D003072
20931330	738	747	donepezil	Chemical	MESH:D000077265
20931330	832	840	patients	Species	9606
20931330	865	871	CYP3A4	Gene	1576
20931330	919	925	CYP3A5	Gene	1577
20931330	995	1001	CYP3A4	Gene	1576
20931330	1005	1011	CYP3A5	Gene	1577
20931330	1033	1042	donepezil	Chemical	MESH:D000077265
20931330	1146	1151	ABCB1	Gene	5243
20931330	1200	1205	1236C	DNAMutation	tmVar:c|Allele|C|1236;VariantGroup:2;CorrespondingGene:5243;RS#:1128503;CorrespondingSpecies:9606
20931330	1206	1211	2677G	DNAMutation	tmVar:c|Allele|G|2677;VariantGroup:1;CorrespondingGene:5243;CorrespondingSpecies:9606
20931330	1212	1217	3435C	DNAMutation	tmVar:c|Allele|C|3435;VariantGroup:0;CorrespondingGene:5243;RS#:1045642;CorrespondingSpecies:9606
20931330	1228	1233	1236T	DNAMutation	tmVar:c|Allele|T|1236;VariantGroup:2;CorrespondingGene:5243;RS#:1128503;CorrespondingSpecies:9606
20931330	1234	1239	2677T	DNAMutation	tmVar:c|Allele|T|2677;VariantGroup:1;CorrespondingGene:5243;CorrespondingSpecies:9606
20931330	1240	1245	3435T	DNAMutation	tmVar:c|Allele|T|3435;VariantGroup:0;CorrespondingGene:5243;RS#:1045642;CorrespondingSpecies:9606
20931330	1253	1261	Patients	Species	9606
20931330	1348	1357	donepezil	Chemical	MESH:D000077265
20931330	1511	1519	patients	Species	9606
20931330	1748	1754	CYP3A4	Gene	1576
20931330	1759	1765	CYP3A5	Gene	1577
20931330	1806	1815	donepezil	Chemical	MESH:D000077265
20931330	1875	1880	ABCB1	Gene	5243
20931330	1914	1923	donepezil	Chemical	MESH:D000077265
20931330	Negative_Correlation	MESH:D000077265	MESH:D000544
20931330	Association	MESH:D000077265	RS#:1128503;HGVS:c.1236C>T;CorrespondingGene:5243
20931330	Positive_Correlation	CorrespondingGene:5243;CorrespondingSpecies:9606;VariantGroup:1;tmVar:c	RS#:1128503;CorrespondingGene:5243
20931330	Positive_Correlation	HGVS:c.2677G>T,A;CorrespondingGene:5243	RS#:1128503;CorrespondingGene:5243
20931330	Association	CorrespondingGene:5243;CorrespondingSpecies:9606;VariantGroup:1;tmVar:c	RS#:1045642;CorrespondingGene:5243
20931330	Association	MESH:D000077265	5243
20931330	Negative_Correlation	MESH:D000077265	MESH:D003072
20931330	Association	MESH:D000077265	CorrespondingGene:5243;CorrespondingSpecies:9606;VariantGroup:1;tmVar:c
20931330	Association	RS#:1045642;CorrespondingGene:5243	RS#:1128503;CorrespondingGene:5243
20931330	Association	CorrespondingGene:5243;CorrespondingSpecies:9606;VariantGroup:1;tmVar:c	RS#:1045642;CorrespondingGene:5243
20931330	Association	CorrespondingGene:5243;CorrespondingSpecies:9606;VariantGroup:1;tmVar:c	RS#:1128503;CorrespondingGene:5243

